• Obstructive Sleep Apnea (“OSA”) is a pervasive disorder impacting the lives of up to 1 billion people globally and approximately 54 million Americans. OSA has been linked to increased rates of cancer, hypertension, cardiovascular disease, ADHD, Alzheimer’s, diabetes, dementia, and ultimately—up to 10-year shorter lifespans.
• Current front-line treatment options such as CPAP are intrusive and must be used every night for life in order to be effective. Surgical options and implants can be risky and expensive.
• The Vivos System is the first treatment modality for mild to moderate OSA which has demonstrated the ability to remodel and enhance the size, shape, and function of the human airway—all within a relatively short time and without the need for lifetime intervention and treatment.

For chronic insomniacs and sleep apnea sufferers the world over, help has finally arrived. A revolutionary remedy developed by Vivos Therapeutics represents a possible solution to the frustrating and potentially life-threatening condition known as Obstructive Sleep Apnea (“OSA”). This innovative medical device technology company has created and patented a novel system to combat OSA caused by deficiencies and other tissue anomalies in craniofacial anatomy development—the root cause behind 98% of OSA cases. The Vivos System requires no surgery but is a multidisciplinary treatment protocol that consists of comfortable and customized oral devices.  Over the typical 18 to 24 month course of treatment, we believe the patient’s upper airway is remodeled and enhanced, thereby reducing the tissue obstructions that gave rise to the OSA.  Thus, Vivos technology represents the first true hope of an effective and lasting non-surgical OSA solution that in most cases, doesn’t require a lifetime of treatment intervention.  For the first time, the salutation “good night” will truly mean a good night for these sufferers.

Years ago, before we understood just how deadly and debilitating OSA truly was, many people actually poked fun at those who suffered from it.  Some erroneously still consider it to be a condition that only affects overweight middle-aged males.  Today, however, we know that patients of all ages, ethnicities, BMI scores, and demographics are at risk.  Even mild-to-moderate sufferers are known to be at much greater risk for virtually all of the major chronic diseases plaguing modern man—cancer, diabetes, hypertension, cardiovascular disease, stroke, Alzheimer’s, ADHD, dementia, fibromyalgia, and more.  The latest research has highlighted the key role that a good night’s rest plays in our overall health and wellness—both mentally and physically.  For those with OSA, it can be impossible to experience the rest and rejuvenation that comes from a good night’s rest.

The severity of OSA is typically measured by what is known as the Apnea Hypopnea Index or AHI.  Simply put, this index tallies up the number of times per hour during the night that the patient stops breathing for at least 10 seconds (an apnea).  Five time or less per hour is considered normal.  Between five and fifteen times is considered mild.  Between 15 and 30 is considered moderate, and 30 or more is considered severe.  Most patients think of snoring when they think of OSA.  The two conditions are related but different, and while almost all OSA patients snore, not all snorers have OSA.  Only a polysomnogram or home sleep test can tell for sure.  Those tests will measure a number of parameters that go on during sleep, and from that data an AHI score can be derived.

The latest diagnostic technology from SleepImage, which recently received FDA clearances, can actually detect and render a medical diagnosis for OSA via a single sensor device worn on the wrist.  The technology uses the latest advances in cardiopulmonary coupling to derive not only an AHI score, but also provide many other important indicators of sleep quality.  Given the fact that 80% or more of all patients believed to have OSA remain undiagnosed and untreated, the growing ability to screen and identify potential sufferers is creating more and more patients seeking treatment.  As this happens, Vivos Therapeutics is well positioned to be the treatment of choice.

The current medical “Gold Standard” for the non-surgical treatment of OSA is continuous positive airway pressure (or CPAP).  These systems consist of a machine that blows air through a tube connected to a face mask worn by the sleeper. They are generally effective at alleviating symptoms, but can be uncomfortable, poorly tolerated and obtrusive to use and maintain.  In addition, they can affect the quality of sleep of both sufferers and their partners.  In stark contrast, the Vivos System is simple to use and comfortable to wear.  It doesn’t make noise or affect the person laying next to the patient.  It doesn’t harbor mold or bacteria that can lead to respiratory infections and pneumonia.  Most patients report an improvement in their rest and overall energy levels within days or a few short weeks of treatment.

The remodeling and airway enhancement effects of the Vivos System are referred to as Pneumopedics(R).  Think of it like the three-dimensional expansion of a balloon when air is blown into it.  Pneumopedics is a natural process induced by the company’s proprietary biomimetic technology, which is believed to remodel airway tissues to increase their size, shape and capacity. The system was developed using expertise drawn from a number of medical and dental specialties, particularly dental practitioners who have completed advanced training in craniofacial sleep medicine. Unlike many other approaches, the Vivos System aims for a lasting resolution by targeting the root cause of obstructive sleep apnea: abnormal development of the craniofacial anatomy.

Central to the success of the company is its ability to recruit and train dentists in the proper integration of the Vivos System into their practices.  The company currently has over 1,350 trained providers throughout North America, with others scattered around the world.  The company regularly conducts online continuing education and other training broadcasts that expose this revolutionary technology to dentists and other healthcare providers on a global scale.  This year to date the company has presented at least some portion of its overall continuing education program on airway development and the central role of dentistry to over 47,000 clinicians and staff members worldwide.

For more information, visit the company’s website at www.VivosLife.com.

NOTE TO INVESTORS: The latest news and updates relating to Vivos Therapeutics are available in the company’s newsroom at http://ibn.fm/VVOS

• Pure Extracts is the development leader in the Canadian cannabis extract segment, which is valued by Deloitte at $2.7 billion annually.
• The Company is positioned to be the dominant extraction company and a leader in the rapid development and commercialization of functional and medicinal psychedelic products.
• The psychedelic and functional mushroom industries are among the fastest growing in North America, with the global medicinal mushroom market expected to grow by $13.88 billion annually by 2024.
• Growing societal awareness and acceptance of mental illness as a legitimate disease have served as catalysts for a new search for innovative treatments and, as a result, interest in psychedelics.
• Current research is finding psychedelic benefits including anti-tumor, anti-viral, detoxification, immune function, and mental wellness. As such, psychedelic compounds are now being examined by leading medical research and academic institutions for the treatment of depression, PTSD, anxiety, bi-polar disorder, obesity, narcolepsy, OCD, Alzheimer’s, ADHD and drug and alcohol dependence.

Pure Extracts Corp., headquartered in Pemberton, British Columbia, is a private, plant-based extraction company with a new vertical in functional mushrooms. The firm is positioned to be the dominant extraction company and a leader in the rapid development and commercialization of functional and medicinal psychedelic products.

The Company’s business model consists of three verticals: in-house brands; toll processing, offering contract cannabis and hemp processing to Canadian Licensed Producers and international partners to sell under their own brands; and white labelling, supplying products, including edibles and custom formulated oils, in consumer-ready packaging for companies licensed to sell cannabis oil extracts and for CPG brands seeking licensed cannabis manufacturing partners.

Market Position

The psychedelic and functional mushroom industries are among the fastest growing in North America. As the industry transitions from dry biomass to extracts, many companies are unprepared for this new opportunity. The global medicinal mushroom market is expected to grow by $13.88 billion annually by 2024.

When assessing investment strategy, market analysts suggest that psychedelics are more comparable to biotech than to cannabis. Unlike traditional biotech, however, psychedelics can claim years of human consumption. Because their efficacy and safety are already well understood, the hurdles for development are likely to be lower. As known molecules, psychedelics won’t spend as much time in discovery and pre-clinical development.

Current research is finding psychedelic benefits including anti-tumor, anti-viral, detoxification, immune function, and mental wellness. As such, psychedelic compounds are now being examined by leading medical research and academic institutions for treatment of depression, PTSD, anxiety, bi-polar disorder, obesity, narcolepsy, OCD, Alzheimer’s, ADHD and drug and alcohol dependence. In 2020, the FDA granted breakthrough therapy status to psychedelics for treatment-resistant depression, with approvals anticipated in 2021.

Pure Extracts is well positioned to partner with organizations planning to develop both functional and psychedelic products. A dealer’s license with Health Canada will enable buying, selling and producing of psychedelics in an EU-GMP-compliant environment. The Company’s 10,000 square foot facility is designed for EU-GMP certification, which allows for international sales. The Company has signed NDAs to explore joint development endeavors for Q4 2020 product launches, as well as an advisory agreement with Dr. Alexander MacGregor, founder of Transpharm Canada Inc. (“TCI”), the parent company of Toronto Institute of Pharmaceutical Technology, whose facility is a fully compliant Health Canada licensed Good Manufacturing Practice (“GMP”) manufacturing and testing facility and is a full-service clinical development business that provides clinical trial services to biotechnology companies.

Research on Psychedelics

Naturally occurring psychedelics, like psilocybin mushrooms, peyote and ayahuasca, have been used by humans for centuries. First seen as potentially medicinal in 1938 by a chemist at Sandoz Pharmaceuticals (now Novartis), the desired stimulant effect was unsuccessful and therefore the drug was shelved. Twenty years later, in 1958, Sandoz began selling lysergic acid diethylamide (LSD) to treat mental disorders. From 1950 to 1965, over a thousand scientific papers on these compounds were published. During the 1960s, however, psychedelics made their way out of the lab and onto the street. The war on drugs followed, and psychedelic research essentially ended.

Research continued slowly on the fringes. The Multidisciplinary Association for Psychedelic Studies was formed in 1986 with the goal of becoming a leading non-profit psychedelic pharmaceutical company. Still being researched, psychedelics’ primary and most common mechanism of action is agonism of serotonin receptors in the brain, which promotes serotonin production in order to regulate mood.

Growing societal awareness and acceptance of mental illness as a legitimate disease due, in part, to its increasingly prevalence have been a catalyst for a new search for innovative treatments. As such, interest in psychedelic medicines has been revived in recent years.

Extract Segment Leader with Cannabis

Canada’s cannabis industry is dominated by dried flower products. Extract products are estimated to represent only 13% of the market share. With no dominant brands in the cannabis sector, Pure Extracts is the development leader in this segment, which is estimated by Deloitte to be worth $2.7 billion annually. Pure Pulls, the company’s private label brand, is nationally recognized through compliant event sponsorship and ongoing product engagement.

Management Team

Pure Extract is led by a team of dedicated professionals leveraging extensive industry knowledge.

Ben Nikolaevsky, the company’s CEO, has more than a decade of experience in corporate leadership roles across the natural products, agriculture and cannabis sectors. Nikolaevsky has served as CEO at Natura Naturals Inc. and Blue Goose Capital Corp., as well as market vice president at CIBC and chief credit officer & capital markets manager at IBM Global Financing Canada.

Doug Benville founded Pure Extracts and serves as the company’s COO. He is highly proficient in cannabis cultivation, system operations and oil extraction.

Alexander Logie, Pure Extracts’ vice president of business development, has over 30 years of experience in the financial services sector, having most recently served as interim CFO, COO and senior vice president of business development at Natura Naturals Inc., a licensed cannabis producer acquired at the start of 2019.

Andy Gauvin is vice president of sales for Pure Extracts. Gauvin is an accomplished senior sales leader with over 30 years of experience in the cannabis space. Gauvin also brings extensive knowledge of the complex federal and provincial regulatory environment to the Pure Extracts team.

For more information, visit the company’s website at www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts are available in the company’s newsroom at http://ibn.fm/Pure

• Numbers in streaming platform viewership have risen sharply due to COVID-19
• MVES’s economic solutions have made it competitive streaming option while similar businesses have faced financial challenges
• MVES’s innovative approach to streaming differentiates it from other studios

While COVID-19 has had detrimental effects on finances for the film industry and newly-emerging startups, The Movie Studio (OTC: MVES), an independent motion picture production company, has preserved its financial assets through strategic production planning and capitalizing on the surge in digital content consumption.

About 66% of global respondents watch some form of video on demand (“VOD”) programming; out of those respondents, 43% watch VOD programming at least once a day (http://ibn.fm/MkLk7). Furthermore, now that a substantial portion of the workforce has been furloughed at home and movie theaters remain closed for business, the demand for online streaming services has increased drastically.

In the dynamic market of over the top (“OTT”) programming, MVES ‘s business model is proving to be resourceful for the company. The Movie Studio Inc. distinguishes itself from other platforms in that it capitalizes on hiring lesser known actors and actresses in its original motion pictures. By creating films and distributing them on major subscription-based video on demand (“SVOD”) platforms without the expense of recognizable movie stars, MVES has the unique potential to increase production quality and reduce overall capital expenditures.

Episodic movie production is one strategy SVOD providers are using to innovate in the space. MVES’s production goal is to film movies in ten “chapters” and then edit them together to make a complete film. The chapters are then released via The Movie Studio’s App, which currently has 650,000 subscribers and is available for download in the App Store and Google Play. Similar to The Movie Studio’s “chapters,” Quibi (short for “quick bites”) is another OTT streaming platform that produces short-form movies and TV shows, with each episode being less than 10 minutes. However, Quibi has had some financial struggles, as “the advertisers, which include PepsiCo Inc., Yum Brands Inc.’s Taco Bell, Anheuser-Busch InBev SA BUD, and Walmart Inc. have asked for the changes because of concerns about the service’s low viewership or the impact of the coronavirus pandemic on their businesses” (http://ibn.fm/uG2Jd). Though staying afloat in the highly competitive OTT/VOD market can prove difficult, The Movie Studio’s unique strategy of minimizing capital production expenses historically associated with blockbuster film production positions it to potentially disrupt the evolving industry.

The Movie Studio Inc. has the advantage of being founded in 1961 with established experience in the motion picture industry. The vertically integrated company has an objective in developing, manufacturing, and distributing independent film content for worldwide consumption. MVES is the only major independent studio located in South Florida that manages its own in-house marketing and distribution department, and its unique revenue-oriented growth strategy positions it as a leading candidate to address the challenges within the field other competitors are struggling to alleviate.

Due to the fallout from the COVID-19 pandemic, the movie industry is changing. As citizens are limited in going out freely, visiting theaters to see the latest films, the industry is responding by bringing these options to the home TV screen.  Over the top cable services—Roku, Binge Networks, Hulu—are options with downloadable movies. How timely for them to be in this Video on Demand industry—allowing for a totally customizable experience. The most recent release that came out from DreamWorks Animation–Trolls—came out on demand. The world is shifting to an on-demand format, and The Movie Studio Inc. is poised to meet those demands.

For more information, visit the company’s website at www.TheMovieStudio.com

NOTE TO INVESTORS: The latest news and updates relating to MVES are available in the company’s newsroom at http://ibn.fm/MVES

• Company announced its BudCars Cannabis Delivery Service racked up 58% month over month sales growth
• SGMD CEO notes that “we believe our daily sales in the LA area could triple that figure relatively quickly”
• In addition to impressive sales figures, Sugarmade maintained extremely strong supplier relationships

Sugarmade (OTCQB: SGMD), an early pioneer within California’s regulated cannabis industry, has seen record-breaking sales numbers with its latest cannabis venture: Budcars Cannabis Delivery Service. In a recent announcement, SGMD reported 58% month over month sales growth for the Sacramento-based subsidiary, which is slated to expand into the Los Angeles area this summer (http://ibn.fm/2DzuN).

“We did about $6,000 per day in sales in March and over $9,500 per day in April, representing a very robust growth trend at our Sacramento hub,” said Sugarmade CEO Jimmy Chan. “May is [looking] better than $11,000 per day, demonstrating continued dramatic growth. And investors should also note that this $11,000 per day figure represents activity in only one area. With our LA hub set to come online at the start of summer, and with the unprecedented stay-at-home extension in that region, we believe our daily sales in the LA area could triple that figure relatively quickly.”

Chan noted that the reported numbers represented record growth for BudCars, with sales growing 58% on a sequential monthly basis over March sales on an average daily-volume basis. In addition, he explained, May numbers show a strong continuation of that trend, with sales forecast to add another 16% beyond the record-breaking figured reported in April.

In addition to the impressive sales figures, Sugarmade has maintained strong supplier relationships. Some reports indicate that the California cannabis market may see widespread supply shortages in the coming weeks. Sugarmade “sees low risk of any issues in securing forward product inventories,” the company announced. “Furthermore, as the company’s competitors run into potential issues in securing their own inventory for distribution, management believes BudCars will likely see market share gains, providing another potential driver for near-term sales growth.”

While the Sugarmade is dedicated to providing unparalleled service in Sacramento, company officials are also focusing on expanding BudCars Cannabis Delivery Service in Southern California, starting with a Los Angeles hub, slated for a July opening. With continued stay-at-home orders throughout the Los Angeles County, expectations for the BudCars LA launch are high.

“We are starting to see a market context where supplier relationships matter more than just about anything else, which plays to our strengths,” Chan said. “Demand growth continues to be off the charts across the California cannabis market, and producers are struggling to keep up. Those trends are pairing up with both structural and situational forces to provide a huge tailwind for BudCars. In addition, we remain on schedule for a July launch for BudCars Los Angeles, which will conservatively add another $20 million in annualized sales on the top line.”

As one of the few cannabis companies pursuing a vertically integrated business model, SGMD is placing its current focus on the expansion of non-storefront cannabis delivery. In addition to BudCars, the Sugarmade brand portfolio includes CarryOutsupplies.com and SugarRush(TM). Sugarmade has benefitted from a remarkable growth spurt thus far in 2020 and will seek to maintain its recent trajectory going forward.

For more information about the company, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR

• Gold exploration in and around the historically productive Bullfrog mining area in southwestern Nevada is reawakening the potential for it to become a “new, major gold production center”
• Substantial exploration and development activities with reported successes have been achieved by neighboring AngloGold, Coeur Mining, Kinross Gold and Corvus Gold in the Bullfrog Gold District located 125 miles northwest of Las Vegas, Nevada
• Bullfrog Gold Corp. recently completed a 25-holedrill program at its Bullfrog Project and expects to publish assay results after they become available in mid-June
• Barrick Bullfrog Inc, subsidiary of Barrick Gold Corp. produced 2.3 million ounces of gold from the Bullfrog Mining District but ceased operations in 1999 when gold prices were under $300 per ounce. Approximately 1,000,000 ounces were produced from the lands now controlled by Bullfrog Gold.
• BFGC’s 43-101 compliant resources within a base case pit plan were independently estimated at 525,000 ounces at an average grade of 1.02 g/t using a gold cutoff grade of 0.36 g/t and a price of $1,200 per ounce. More than one analyst predicts the possibility of $1,900 per ounce by year’s end and the application of a lower cutoff grade within the base case pit will increase these resources
• Bullfrog Gold recently completed a private placement of primary shares in January 2020 that brought in C$2 million to facilitate the purchase of the lands leased from Barrick and the further exploration and development of the Project

Gold and silver exploration company Bullfrog Gold (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) recently completed a 25-hole strategic drilling program in the historically productive area surrounding Beatty, Nev.

The drilling focused on resource expansions, further defining pit limits, and testing a new exploration target. Assay results will be published as they become available in the coming weeks, according to a news release issued by the company June 9 (http://ibn.fm/QI3go).

“We are fully funded and timely completed this U.S.$500,000+ drill program, having raised C$2,000,000 in January 2020. We anticipate the receipt of assays from 18 holes by June 12, 2020, and intend to release them soon thereafter,” Bullfrog Gold CEO and President David Beling stated in the news release. “The exploration and development potential of our strategic land position is strongly supported by a large database … (with) detailed information on 155 miles of drilling in 1,262 holes in the Bullfrog mine area.”

The hills around Beatty have become one of the most prolific gold exploration areas in the United States during recent years as gold prices have awakened new interest in the metal known as a refuge during economic crises. Contract for Difference (“CFD”) derivatives market trader IG Markets Limited projects gold could rise as far as $1,900 per ounce by the end of the year as investors respond to recessionary conditions amid the ongoing COVID-19 pandemic (http://ibn.fm/Lr4FJ).

Mining in the region was initiated in 1904 and by 1911 approximately 94,000 ounces of gold were produced from several underground mines at an average gold grade of 0.47 ounces per ton. Very little activity occurred thereafter u until the early 1980s with the expansion of resources in two small deposits and the discovery of the 2.0+ million ounce main Bullfrog deposit. From 1989 to 1999 2.3 million ounces from an average ore grade of 0.08 ounces per ton (oz/t) were recovered from three pits and one underground mine (http://ibn.fm/n5IgF).

Operations in the Bullfrog mine area ended in 1999 with depletion of ore reserves and as gold prices fell, and costs rose, leading owner Barrick Bullfrog Inc. to shut down and ultimately complete reclamation of the Project.  However, BFGC has determined that pit expansions and potential exploration discoveries under current marketing and economic conditions could potentially support the resumption of operations using low cost heap leaching compared to the conventional milling process used by Barrick.

Significant infrastructure from Barrick’s operations remains in place at the project, including a primary power line with a substation site, water supply and suitable pit ramps and access roads. No activity has taken place in the Bullfrog area during the last 20 years beyond Barrick’s reclamation and monitoring of its site and BFGC’s bulk sampling of the pits and recent drill program.

Although gold prices are capable of fluctuating along with large market factors, analysts at precious metals investment firm GoldSilver report that gold prices rise in most cases during big stock market drop-offs, and that gold’s “only significant selloff (46% in the early 1980s)” took place immediately after a years-long bull market climb in which prices had risen more than 2,300 percent (http://ibn.fm/XwBx7).

The conditions have led BFGC to not only pursue expansion of two pits with the aim of purchasing Barrick lands currently under a lease/option, but also drill test several prospective exploration targets , including the new Paradise Ridge target,  which is a compelling analog to the Bullfrog deposit  and located one mile to the east. The company believes that its resources and potential and those of neighboring AngloGold, Coeur Mining, Corvus Gold and Kinross Gold are set to “reestablish the Bullfrog Gold District as a potential new, major gold production center in Nevada.”

For more information, visit the company’s website at www.BullFrogGold.com.

NOTE TO INVESTORS: The latest news and updates relating to BFGC are available in the company’s newsroom at http://ibn.fm/BFGC

• PLUS sees million-dollar increases in net revenues, gross profits; significant improvements in operating costs and cash balance.
• Q1 financial results paint picture of healthy company.
• Launch of PLUS CBDRelief brand marks company’s entrance into wellness, relief space of cannabis adult-use market.

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a U.S. cannabis-branded products company, announced its first-quarter financial results (http://ibn.fm/s19nX). The unaudited financial and operational results, reported for the three months ending March 31, 2020, noted an increase in net revenues and gross profits, with an improvement in operating costs and a multimillion-dollar cash balance.

“The start of this year came with a number of difficult decisions that were made in order to accelerate our path to cash flow generation,” said PLUS CEO and co-founder Jake Heimark. “The changes we made helped to cut our cash consumption to less than a fifth of what it was last quarter and, critically, doing so did not undermine our core business, which grew more than 35% quarter-over-quarter.

“Our first-quarter financial results paint the picture of a much healthier business than previous quarters,” he continued. “But the work is far from done. In 2020, we are focused on leveraging our core capabilities to create capital-efficient growth through known distribution channels.”

According to the report filed with the Canadian Securities Exchange (“CSE”), net revenues for the company rose from $3.2 million for Q1 2019 to $4.7 million in Q1 2020—an impressive 46% increase compared to Q1 2019 net revenues of $3.2 million and a 36% increase over last quarter’s revenue of $3.5 million. Company officials noted the growth came primarily from its California adult-use market, with incremental growth attributed to the Nevada adult-use and national hemp-CBD markets.

Plus Products also saw a 35% increase in gross profits compared to the same period last year, rising from $0.70 million in Q1 2019 to $1.7 million for Q1 2020. The filing noted that “higher sales volumes and increasing operational efficiencies in the company’s California production facility diminished the growth of labor and overhead costs relative to sales, thereby increasing gross profits.”

Additional financial highlights included a 31% year-over-year improvement in operating losses, $2.1 million in Q1 2020 from $3.0 million in Q1 2019, and a 75% quarter-over-quarter improvement from Q4 2019’s $8.2 million. Key to this improvement was the company’s January workforce reductions in Q1 2020 as well as fewer upfront investments tied to new-market entry. Finally, PLUS also reported an accumulative $14.2 million in cash and cash equivalents at the end of the quarter.

A business highlight for Q1 2020 include the company’s launch into the wellness and relief space of the California adult-use market with the unveiling of its PLUS CBDRelief brand. Products in this line feature low-THC and high-CBD ratios formulated specifically for cannabis consumers who are looking to cannabis for relief. More than 175 licensed California retailers already carry the brand.

“The majority of our growth initiatives in 2020 will be centered around California,” Heimark said. “Despite experiencing some growing pains, we believe that California unequivocally remains the most valuable market for building a branded-products company in cannabis. In 2019, the state made up 38% of the global adult-use market and is expected to remain 24% of that market through 2024.

“With the two best-selling products in the state, and one of the largest brands in the California edibles market, we believe that we have established an exceptionally valuable position as a company,” he said. “We are excited to take steps that we believe will continue to grow that position throughout the course of this year.”

Plus Products is well positioned for greater growth in California, as well as continued forward progress in Nevada. Of note for investors is that PLUS has a strong management team and a clean capital structure with considerable insider ownership. The company continues to build the world’s largest cannabis brand by applying its successful formula to new products and consumers.

For more information, visit the company’s website at www.PlusProducts.com.

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

• KGS preparing new drilling campaign at Mohave County that includes historic Rosebud Mine
• Historical report based on underground mapping, drilling, sampling reveals hidden potential in Rosebud Mine
• KGS commissioned Burgex Inc. for new NI 43-101 technical report in preparation for drilling

With gold currently topping the list of “safe-haven” investment assets, Kingman Minerals (TSX.V: KGS), a Canadian-based mining company engaged in the acquisition, exploration and development of gold and silver properties in North America, is positioned to profit through a new drill campaign in Mohave County, Arizona. Located in the Music Mountains region, the Mohave Project is comprised of 20 lode claims that include the historic past-producing Rosebud Mine, allowing the company to benefit from the cost efficiencies of revitalizing an already established exploration site.

The popularity of gold as an investment is increasing due to the instability of government-controlled central banks resulting from recent economic events connected to COVID-19. Fears driven by economic uncertainty typically prompt investors to divert assets into gold as a defensive measure against inflation, currency devaluation and the falling value of less tangible assets. KGS is leveraging these challenging economic conditions by implementing a strategy based on returning to historic gold mining sites and extracting the remaining wealth using new technologies.

Forming part of KGS’s Mohave Project, the historic 167-hectare Rosebud Mine was originally discovered as part of the “Gold Rush” era in the 1880s and was mined extensively until the 1930s. While the most accessible resources have already been extracted, modern mining techniques enable the extraction of difficult lodes safely and cost-effectively, giving KGS the ability to tap into the new wealth left behind by previous mining generations.

Renewed interest in the Rosebud site by KGS is primarily driven by underground mapping, drilling and sampling of the area conducted between 1984 and 1986 by L.A. Bayrock Ph.D. P.Geo. on behalf of Stellar Resource Corporation (http://ibn.fm/4lFpW). The proposed drilling site includes eight separate veins and one prominent double vein which extends from the northwest corner to nearly the southeast corner of the claims block. Written prior to NI 43-101 regulations, the results are not NI 43-101 compliant and require additional underground sampling for verification. KGS has started the process of preparing an NI 43-101-compliant technical report on its Mohave County assets by commissioning the services of Burgex Inc. (http://ibn.fm/IiC7x), a mining consulting services company specializing in the analysis of abandoned mine sites throughout the western United States.

Formerly known as Astorius Resources Ltd., KGS is engaged in the acquisition, exploration and development of gold and silver properties in North America. Based in Canada, the company is focused on sourcing and developing high-quality properties with significant mining potential as part of its strategy of developing a diverse portfolio of low-cost, lifelong assets.

For more information, visit the company’s website at www.KingmanMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to KGS are available in the company’s newsroom at http://ibn.fm/KGS

• MVES using blockchain technology to address management of creative rights, digital piracy, distribution complexity
• Company scheduled to release new films, establishing partnerships to meet increased consumer demand for streaming content
• Traditional satellite, cable services losing 12,000 consumers daily
• VOD subscriptions quadrupled to over 600 million as of 2019, global growth of OTT revenue expected top $129 billion by 2023

The Movie Studio (OTC: MVES) is a vertically integrated motion picture production and distribution company that engages in the acquisition, development, production and distribution of independent motion picture content for worldwide consumption with a focus on video on demand (“VOD”), foreign sales and various media devices. In tune with the recent release of the company’s corporate overview, President and CEO Gordon Scott Venters outlined several significant milestones the company has achieved as it continues expansion of its vertically integrated film production and distribution architecture that utilizes over-the-top (“OTT”) distribution platforms and blockchain technology.

MVES is taking the opportunity to leverage blockchain as the innovative technology provides valuable opportunities to address issues related to the management of creative rights, digital piracy, and distribution complexity. The decentralized nature of blockchain technology is key. It ensures that tampering or takeover of proprietary content is virtually impossible through the use of smart contracts that can register and enforce distribution as well as release agreements between distribution partners and content producers.

Incorporation of blockchain technology is only one part of the innovative changes taking place across the digital landscape of the industry. As part of the film distribution and production space, VOD has undergone a massive shift in the last decade—and this shift has only accelerated as a result of COVID-related lockdowns that increased consumer demand for entertainment.

“The consumption of VOD content has significantly increased with the disruption of movie theater destinations and other forms of on-site entertainment, and we anticipate this trend will continue in the long term,” commented Venters as part of his statements. “We have recently integrated a platform that enables worldwide distribution of licensed movie content. We also recently announced that The Movie Studio has licensed several films, including ‘Bad Actress’ and ‘Exposure’ for distribution in Australia.”

In addition to these new releases, MVES has a number of entertainment projects in the development pipeline that show potential to meet increased consumer demand for VOD entertainment. Besides signing an agreement with Filmhub for the licensing and distribution of motion pictures, the company has also entered into a memorandum of understanding with BINGE Networks LLC, an award-winning streaming media platform that will provide MVES the rights to syndicate and monetize content globally for the streaming media industry.

VOD is experiencing explosive growth as more people sign on for subscriptions while disengaging with traditional satellite and cable services to the tune of 12,000 consumers each day (http://ibn.fm/Zt6z3). Platforms like Disney+ and Netflix have added 50 million (http://ibn.fm/4PoyQ) and 16 million (http://ibn.fm/x6Omj) new subscribers respectively in recent months as part of the global shift to online streaming service subscriptions—the volume of which has quadrupled to over 600 million as of 2019 (http://ibn.fm/Tl4IF). With worldwide subscribers expected to top 1.1 billion by 2021 (http://ibn.fm/s1GMl), global growth of OTT revenue is expected to rise from $69 billion in 2018 to $129 billion by 2023 (http://ibn.fm/y5dWg).

MVES has a creatively designed business model that is expected to massively benefit from this trend through its growth-by-acquisition strategy, proposed strategic alliances and acquisitions, resolution upgrades and unique monetization initiatives. The company’s innovative production model includes user-driven initiatives such as the “Everyone’s a Star” component of their OTT platform that gives viewers the opportunity to upload auditions through the digital app for the chance to participate in upcoming movies. The company’s innovative production model includes filming motion pictures in “chapters” or “Moviesodes” that are distributed in quick clips via the platform, giving subscribers the opportunity to participate in upcoming productions and further driving user engagement.

With a unique business model capitalizing on the increasing global demand for streaming entertainment content, MVES has the potential to emerge as a unique brand in the industry. The company’s innovative use of technology, production process and user engagement strategy give it the opportunity to realize high returns on investment as it continues to leverage the changing landscape of video-based entertainment.

For more information, visit the company’s website at www.TheMovieStudio.com

NOTE TO INVESTORS: The latest news and updates relating to MVES are available in the company’s newsroom at http://ibn.fm/MVES

• XRO enters agreement with Clean Seed Capital to integrate patented technology into high-tech seeder, planter platforms
• Exro CEO calls agreement “another step in the commercialization of Exro’s technology that will expand the capabilities of the world’s electric motors”
• Worldwide exclusive collaboration and supply agreement sets new benchmarks in the electrification of agriculture

Canada-based Exro Technologies (CSE: XRO) (OTCQB: EXROF), one of the world’s proven leaders in the innovation and manufacturing of electric motors, announced that it has signed a deal with Clean Seed Capital, an agricultural company renowned for the development and implementation of highly advanced seeding and planting platforms (http://ibn.fm/Gf4Bw). The agreement will integrate Exro’s technology into Clean Seed’s high-tech agricultural seeder and planter platforms, advancing the electrification of the world’s heavy-farm equipment.

“This is another step in the commercialization of Exro’s technology that will expand the capabilities of the world’s electric motors,” said Exro CEO Sue Ozdemir, who has outlined a plan for the company to finalize eight deals this year in its overarching goal of commercializing its game-changing technology. “Clean Seed is a pioneer in improving the efficacy and sustainability of farming. With this new agreement, we will, together, electrify the industry to maximize its potential, driving better productivity and efficient use of energy.”

Based on the agreement, Clean Seed will issue a purchase order to integrate Exro’s electric-motor-enhancing technology into Clean Seed’s latest technology offerings and beyond. The two companies will collaborate in the effort to build a working prototype that will be implemented in the field by 2021.

The addition of Exro’s patented technology should further enhance Clean Seed’s SMART Seeder(TM) technologies by reducing the power requirements to operate its revolutionary tools that put row-by-row, variable-rate seeding technology into the hands of farmers and allowing those farmers to leverage the latest in agricultural innovation and sustainability. In addition, both companies also plan to develop after-market retrofit products featuring Exro technology to further expand and accelerate the electrification of agricultural farm equipment.

“This worldwide exclusive collaboration and supply agreement with Exro will set new benchmarks in the electrification of agriculture,” said Clean Seed CEO Graeme Lempriere. “This collaboration will benefit the agricultural community by promoting good stewardship of our resources. It has been a pleasure getting to know the team at Exro and we look forward to working together to electrify the agricultural industry and usher in a new sustainable application.”

Clean Seed is comprised of a team of innovators and business management professionals with a proven track record of game changing innovation and production of patented agricultural technologies at a high level. The company focuses on being a progress facilitator that turns solutions for modern agricultural problem into commercially viable products to fulfill new demands.

“The Clean Seed agreement represents Exro’s fifth commercialization deal,” said Ozdemir, who joined Exro as CEO in September 2019 after serving as CEO of GE’s Industrial Motors Division. “As we have set out in our company plan, we have now strategically placed Exro’s technology with respected leaders in the agriculture, automotive, marine, recreational and electric-bicycle markets.”

Exro is a clean-tech company that has developed a new class of control technology for electric powertrains. Exro’s advanced motor-control technology — Coil Driver — expands the capabilities of electric motors and powertrains. Exro offers increased drive cycle efficiency, reduced system volume, reduced weight, and expanded torque and speed capabilities. Exro allows the application to achieve more with less energy consumed.

For more information, visit the company’s website at www.Exro.com.

NOTE TO INVESTORS: The latest news and updates relating to EXROF are available in the company’s newsroom at http://ibn.fm/EXROF

• Energy Fuels is the largest uranium miner in the U.S., owns the White Mesa Mill, the only uranium mill operating in the country today
• The White Mesa Mill is the only facility in the U.S. capable of recycling alternate feed materials and recovering uranium that would otherwise be lost to disposal
• Since 1998 the White Mesa Mill has recycled enough uranium to replace the energy contained in a 4,700-mile coal train stretching from LA to NY — and over 90% of the way back again

Energy Fuels (NYSE American: UUUU) (TSX: EFR) is arguably one of the most environmentally responsible companies operating in the United States today. The company’s main business, uranium production, is “green,” as uranium is used to create fuel for zero-carbon, zero-emission, base-load nuclear energy. However, the company’s alternate-feed material recycling program flies much further under the radar — and this is the most sustainable aspect of Energy Fuels’ business.

In the simplest terms, alternate feeds are uranium-bearing materials that don’t come from uranium mines. They are often waste streams generated from nonuranium mines or a variety of other industrial activities. These materials would normally have to be disposed of permanently in low-level, radioactive-waste or similar disposal facilities. Instead, Energy Fuels is able to recycle alternate feeds and produce clean-energy resources.

Indeed, the White Mesa Mill is the only facility in the United States licensed and designed to recycle alternate-feed materials. Since 1998, the White Mesa Mill has recycled and recovered approximately 6 million pounds of uranium from alternate-feed materials and tailings recycling.

To provide some context around 6 million pounds of recycled uranium, consider the following:

• This is enough uranium to fuel more than 13 nuclear reactors for one year.
• This uranium would produce the same amount of electricity as nearly 50 million tons of coal, or enough coal to fill a train that stretches from Los Angeles to New York and almost all the way back again.
• This would fuel the same amount of annual electricity as over 24,500 wind turbines.
• The use of this recycle uranium eliminates over 85 million tons of CO2 emissions compared to coal, or the annual emissions of over 18 million passenger vehicles.
• The use of this material also avoids significant mining and waste containment.

Besides recycling uranium, Energy Fuels also recycles vanadium. In addition to being the only conventional uranium mill in the U.S., the White Mesa Mill is the only conventional vanadium mill in the country. Vanadium is used in steel, titanium and other high-strength alloys. The mineral is also being increasingly used in high-capacity, community-scale batteries that store intermittent renewable energy sources, such as wind and solar.

In 2019, Energy Fuels recycled 1.8 million pounds of vanadium. This is enough vanadium used in steel to build four and a half Golden Gate Bridges from scratch. And now, the company is entering the rare earth elements (REE) space, which also involves the recycling of REE-bearing materials. Indeed, the White Mesa Mill may be able to play an important role in bringing REE production back to the U.S.

Energy Fuels has a phenomenal, but largely unknown, recycling story that no other U.S. uranium producer – or any other company for that matter — can tell. The company might be one of the biggest recyclers of clean energy resources in the country — and potentially even the world.

For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU